Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users

This publication has 41 references indexed in Scilit:

• Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection
  Gastroenterology, 2010
• Hepatitis C Treatment for Injection Drug Users: A Review of the Available Evidence
  Clinical Infectious Diseases, 2009
• Review article: adherence to medication for chronic hepatitis C – building on the model of human immunodeficiency virus antiretroviral adherence research
  Alimentary Pharmacology & Therapeutics, 2009
• Diagnosis, management, and treatment of hepatitis C: An update # † ‡
  Hepatology, 2009
• Adherence to Hepatitis C Virus Therapy and Early Virologic Outcomes
  Clinical Infectious Diseases, 2009
• Patient education improves adherence to peg-interferon and ribavirin in chronic genotype 2 or 3 hepatitis C virus infection: A prospective, real-life, observational study
  World Journal of Gastroenterology, 2008
• The New International Health Regulations: An Historic Development for International Law and Public Health
  Journal of Law, Medicine & Ethics, 2006
• The short‐form version of the Depression Anxiety Stress Scales (DASS‐21): Construct validity and normative data in a large non‐clinical sample
  British Journal of Clinical Psychology, 2005
• Barriers to interferon-α therapy are higher in intravenous drug users than in other patients with acute hepatitis C
  Journal of Hepatology, 2005
• Efficacy of a 24-week course of PEG-interferon α-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance
  Journal of Hepatology, 2004